Ji Young Lee

Dr. Ji Young Lee

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2021 in Cancers
Verified
Journal Article
Open access
PDF file
HPHyun-Soo Park
Hyun-Soo Park
Kwang-sig LeeKwang-sig Lee
Kwang-sig Lee
BSBo Kyoung Seo
Bo Kyoung Seo
EKEun-Sil Kim
Eun-Sil Kim
KCKyu Ran Cho
Kyu Ran Cho
JCJaehyung Cha
Jaehyung Cha
This prospective study enrolled 147 women with invasive breast cancer who underwent low-dose breast CT (80 kVp, 25 mAs, 1.01–1.38 mSv) before treatment. From each tumor, we extracted eight perfusion parameters using the maximum slope algorithm and 36 texture parameters using the filtered histogram technique. Relationships between CT parameters and histological factors were analyzed using five machine learning algorithms. Performance was compared using the area under the receiver-operating characteristic curve (AUC) with the DeLong test. The AUCs of the machine learning models increased when using both features instead of the perfusion or texture features alone. The random forest model that integrated texture and perfusion features was the best model for prediction (AUC = 0.76). In the integrated random forest model, the AUCs for predicting human epidermal growth factor receptor 2 positivity, estrogen receptor positivity, progesterone receptor positivity, ki67 positivity, high tumor grade, and molecular subtype were 0.86, 0.76, 0.69, 0.65, 0.75, and 0.79, respectively. Entropy of pre- and postcontrast images and perfusion, time to peak, and peak enhancement intensity of hot spots are the five most important CT parameters for prediction. In conclusion, machine learning using texture and perfusion characteristics of breast cancer with low-dose CT has potential value for predicting prognostic factors and risk stratification in breast cancer patients.

3 January 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JPJi Yeon Park
Ji Yeon Park
JLJi Young Lee
Ji Young Lee
SYSeong Yoon Yi
Seong Yoon Yi
Purpose: This study aimed to assess the incidence of axillary lymphadenopathy on ultrasound after COVID-19 vaccination and to investigate the factors affecting lymphadenopathy. Methods: We evaluated patients who had received a COVID-19 vaccination within 12 weeks before an ultrasound examination between August and October 2021. The incidence of vaccine-related ipsilateral axillary lymphadenopathy was evaluated using ultrasound. Age, sex, presence of axillary symptoms, injection site, vaccine type, interval from vaccination, and dose were compared between the groups with and without axillary lymphadenopathy. Results: We included 413 patients, 202 (49%) of whom showed axillary lymphadenopathy on ultrasound after COVID-19 vaccination. Age, interval from vaccine, vaccine brand, vaccine type, dose, and symptom were significantly different between the lymphadenopathy and non-lymphadenopathy groups (p < 0.001), while the injection site and sex were not. Receiving an mRNA vaccine was the most important factor for axillary lymphadenopathy (p < 0.001), followed by intervals of 1–14 (p < 0.001) and 15–28 days (p < 0.001), younger age (p = 0.006), and first dose (p = 0.045). Conclusion: COVID-19 vaccine-related axillary lymphadenopathy on ultrasound is common. mRNA type, an interval of 4 weeks, younger age, and first dose were the important factors. Breast clinicians should be well aware of these side effects when performing imaging examinations and provide accurate information to patients.

23 February 2016 in Iranian Journal of Radiology
Verified
Journal Article
Open access
PDF file
SBSuk Hyun Bae
Suk Hyun Bae
JLJi Young Lee
Ji Young Lee
Dermatofibrosarcoma protuberans is an uncommon malignant mesenchymal tumor of the dermis, which most commonly appears on the body and extremities. A preoperative diagnosis of dermatofibrosarcoma protuberans is extremely difficult, because it is a very rare entity and its appearance is often similar to that of benign breast lesion. Here, we presented a case of breast dermatofibrosarcoma protuberans with associated radiological mammography, ultrasound, magnetic resonance imaging and fludeoxyglucose-positron emission tomography computerized tomography (FDG-PET CT) features. To our knowledge, our case is the first report of PET-CT findings of breast dermatofibrosarcoma protuberans. Furthermore, we reviewed characteristic radiologic features of this rare entity, which are helpful for differentiating it from other primary benign breast lesions. Keywords: Dermatofibrosarcoma Protuberans; Breast; Ultrasound; MRI; PET

1 January 2010 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
BKBo Mi Kim
Bo Mi Kim
JLJi Young Lee
Ji Young Lee
YHYoon Hee Han
Yoon Hee Han
SKSu Young Kim
Su Young Kim
JSJung Wook Seo
Jung Wook Seo
ELEung Soo Lee
Eung Soo Lee
Kim BM, et al. Korean J Radiol. 2010 May-Jun;11(3):364-367. http://dx.doi.org/10.3348/kjr.2010.11.3.364

1 July 2015 in Clinical Imaging
Verified
Journal Article
Closed access
SLSo Min Lee
So Min Lee
JLJi Young Lee
Ji Young Lee
BLByung Hoon Lee
Byung Hoon Lee
SKSu Young Kim
Su Young Kim
MJMee Joo
Mee Joo
JKJae Il Kim
Jae Il Kim

1 May 2019 in Radiology Case Reports
Verified
Journal Article
Open access
JKJi Hee Kim
Ji Hee Kim
JLJi Young Lee
Ji Young Lee
Phyllodes tumors are rare neoplasms that account for 2.5% of all fibroepithelial lesions, and 10%-20% exhibit malignant transformation. Malignant transformation often occurs in the form of stroma, and usually shows fibrosarcomatous differentiation. Liposarcomatous differentiation is a rare, developed stromal component of phyllodes tumors, and little is known about their imaging findings. We present the case of a 47-year-old woman who was diagnosed with a malignant phyllodes tumor of the breast that contained liposarcomatous elements. The patient underwent wide surgical excision of the mass and has been treated with adjuvant radiation therapy.